Clinical Trial Update: Synchronized Cardiac Assist for Cardiogenic Shock

View source ↗

Summary

A completed clinical trial evaluating synchronized cardiac assist for patients with cardiogenic shock, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Synchronized Cardiac Assist

Snippet

Sponsor: Xenios AG | Conditions: Shock, Cardiogenic, High Risk Percutaneous Coronary Interventions | Status: COMPLETED | Results posted: 2022-09-16